Klotho Neurosciences (KLTO)

• Market cap: $21.3M
• 1 day: -5.48%
• 5 days: -11.21%
• 1 month: -9.18%
• 3 months: -44.15%
• 6 months: -74.07%
• Year to date: -8.29%
• 1 year: -30.24%
• 5 years: -97.04%
• 10 years: -97.04%
• Sector: Healthcare
• Industry: Biotechnology

About: Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

Employees: 3